Applying the Molecular Adsorbent Recirculating System (MARS) in the Treatment of Acute Liver Failure (ALF) Case Report

1. Bernal W, Wendon J. Acute Liver Failure. N Engl J Med 2013; 369: 2525-34.10.1056/NEJMra1208937Search in Google Scholar

2. Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, López SA, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-40.10.3748/wjg.v21.i42.12125Search in Google Scholar

3. Olin P, Hausken J, Foss A, Karlsen TH, Melum E et Haugaa H. Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation. Scandinavian Journal of Gastroenterology. 2015; 50: 1127-34.10.3109/00365521.2015.1027262Search in Google Scholar

4. Krisper P, Stadlbauer V, Stauber RE. Clearing of toxic substances: are there differences between the available liver support devices? Liver Int 2011; 31: 5–8.10.1111/j.1478-3231.2011.02588.xOpen DOISearch in Google Scholar

5. Faybik P, Krenn CG. Extracorporeal liver support. Curr Opin Crit Care 2013; 19: 149–53.10.1097/MCC.0b013e32835eb970Open DOISearch in Google Scholar

6. Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al. Extracorporeal albumin dialysis with the molecular adsorbence recirculating system in acute-onchronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153–62.10.1002/hep.26185Search in Google Scholar

7. Cisneros-Garza LE, del Rosario Muñoz-Ramírez M, Muñoz-Espinoza LE, Ruiz Velasco JAV, Moreno-Alcántar R, Marín-López E. The molecular adsorbent recirculating system as a liver support system. Summary of Mexican experience. Ann Hepatol 2014; 13(2): 240-7.10.1016/S1665-2681(19)30887-7Search in Google Scholar

8. Pares A, Deulofeu R, Cisneros L, Escorsell A, Salmeron JM, Caballeria J, et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009; 13: R8.10.1186/cc7697268812019175915Search in Google Scholar

9. Chiu A, Tsoi NS, Fan ST. Use of the molecular adsorbents recirculating system as a treatment for acute decompensated Wilson disease. Liver Transpl 2008; 14: 1512–16.10.1002/lt.2155318825711Search in Google Scholar

10. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-98.Search in Google Scholar

11. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure — one disease, more than 40 definitions. Aliment Pharmacol Ther 2012; 35: 1245-56.10.1111/j.1365-2036.2012.05097.x22506515Search in Google Scholar

12. Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res 2008; 38: 970-9.10.1111/j.1872-034X.2008.00368.x18462374Search in Google Scholar

13. Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat 2005; 12(2): 192–8.10.1111/j.1365-2893.2005.00581.x15720535Search in Google Scholar

14. Brochard L, Abroug F, Brenner M et al. An Official ATS/ERS/ESICM/SCCM/SRLF Statement:Prevention and management of acute renal failure in the ICU patient: An international consensus conference in intensive care medicine. Am J Resp Crit Care Med 2010; 181: 1128-55.10.1164/rccm.200711-1664ST20460549Search in Google Scholar

15. Kelly JA, Lameire N and the KDIGO Work Group. KDIGO Clinical Practice Guideline for Acute kidney injury. Kidney International 2012; 2(1).Search in Google Scholar

16. Wadei H, Mai M, Ahsan N, Gonwa T. Hepatorenal syndrome: patho-physiology andmanagement. Clin J Am Soc Nephrol 2006; 1: 1066-79.10.2215/CJN.0134040617699328Search in Google Scholar

17. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification. Hepatology 2002; 35: 716-21.10.1053/jhep.2002.3125011870389Open DOISearch in Google Scholar

18. Schiodt FV, Ostapowicz G, Murray N et al. Alphafetoprotein and prognosis in acute liver failure. Liver Transplant 2006; 12: 1776-81.10.1002/lt.2088617133565Search in Google Scholar

19. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005; 41: 26–31.10.1002/hep.2051115690478Open DOISearch in Google Scholar

20. Kakisaka K, Kataoka K, Onodera M, Suzuki A, Endo K, Tatemichi Y et al. Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure, Hepatology Research 2015; 45(10): E12-E20.10.1111/hepr.1244825376981Search in Google Scholar

21. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45–53.10.1002/hep.2096916447274Search in Google Scholar

22. Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study. Critical Care 2016; 20(1): 210.1186/s13054-015-1159-3469925226728364Search in Google Scholar